219 related articles for article (PubMed ID: 1904181)
41. [IgM myeloma. Report of 2 cases].
Pamies Andreu E; Sánchez Román J; Noguer Mediavilla M; Arca Sosa V
Rev Clin Esp; 1986 Oct; 179(6):305-7. PubMed ID: 3099344
[No Abstract] [Full Text] [Related]
42. [Light chain disease with terminal myocardiopathy].
Laurent M; Toulet R; Ramée MP; Legrand D; Le Normand JP; Lelguen C
Arch Mal Coeur Vaiss; 1985 Jun; 78(6):943-6. PubMed ID: 3929722
[TBL] [Abstract][Full Text] [Related]
43. [Case of IgD kappa multiple myeloma].
Przybyłowski J; Bartelik S; Slefarska H; Siedlecki J
Przegl Lek; 1983; 40(8):643-5. PubMed ID: 6420847
[No Abstract] [Full Text] [Related]
44. Clinicopathologic correlations in multiple myeloma: a case series of 190 patients with kidney biopsies.
Nasr SH; Valeri AM; Sethi S; Fidler ME; Cornell LD; Gertz MA; Lacy M; Dispenzieri A; Rajkumar SV; Kyle RA; Leung N
Am J Kidney Dis; 2012 Jun; 59(6):786-94. PubMed ID: 22417785
[TBL] [Abstract][Full Text] [Related]
45. [Polyclonal immunoglobulins in serum in obligatory and facultative monoclonal gammopathies].
Hrncírová L; Máchová L
Vnitr Lek; 1982 Feb; 28(2):116-21. PubMed ID: 6801853
[No Abstract] [Full Text] [Related]
46. [Kappa light chain disease. Apropos of 2 anatomical cases of myeloma].
Auriol M; Beaufils H; Delcourt A; Raphaël M; Bellefqih S; Chomette G
Arch Anat Cytol Pathol; 1985; 33(4):209-13. PubMed ID: 3933439
[No Abstract] [Full Text] [Related]
47. Light chain deposition disease in multiple myeloma: MR imaging features correlated with histopathological findings.
Baur A; Stäbler A; Lamerz R; Bartl R; Reiser M
Skeletal Radiol; 1998 Mar; 27(3):173-6. PubMed ID: 9554011
[TBL] [Abstract][Full Text] [Related]
48. Successful treatment with bortezomib and dexamethasone for proliferative glomerulonephritis with monoclonal IgG deposits in multiple myeloma: a case report.
Noto R; Kamiura N; Ono Y; Tabata S; Hara S; Yokoi H; Yoshimoto A; Yanagita M
BMC Nephrol; 2017 Apr; 18(1):127. PubMed ID: 28385149
[TBL] [Abstract][Full Text] [Related]
49. Multiple myeloma and multiple plasmacytomas associated with free gamma heavy chain, free kappa light chain and IgGk paraproteins: an unusual triple gammopathy.
Deighan WI; O'Kane MJ; McNicholl FP; Keren DF
Ann Clin Biochem; 2016 Nov; 53(6):706-711. PubMed ID: 27166317
[TBL] [Abstract][Full Text] [Related]
50. Coexistence of myelodysplastic syndrome and multiple myeloma.
Tsiara S; Economou G; Panteli A; Isaakidis P; Kapsali E; Bourantas KL
J Exp Clin Cancer Res; 1999 Dec; 18(4):565-6. PubMed ID: 10746986
[TBL] [Abstract][Full Text] [Related]
51. Multiple myeloma with massive proteinuria and terminal renal failure.
Ooi BS; Pesce AJ; Pollak VE; Mandalenakis N
Am J Med; 1972 Apr; 52(4):538-46. PubMed ID: 4622778
[No Abstract] [Full Text] [Related]
52. [IgD/kappa myeloma].
Golenkov AK; German GP; Zlatkina AR; Chernokhvostova EV; Cheredeev AN
Ter Arkh; 1984; 56(11):129-31. PubMed ID: 6441298
[TBL] [Abstract][Full Text] [Related]
53. [Morphological and immunochemical features of nephropathies in multiple myeloma and severe renal failure].
Rechtina IG; Golitsina EP; Varlamova EIu; Varshvskiĭ VA; Kireeva AA; Biriukova LS; Savchenko VG
Ter Arkh; 2013; 85(3):80-5. PubMed ID: 23720848
[TBL] [Abstract][Full Text] [Related]
54. Light chain crystal deposition as a manifestation of plasma cell dyscrasias: the role of immunoelectron microscopy.
Gu X; Barrios R; Cartwright J; Font RL; Truong L; Herrera GA
Hum Pathol; 2003 Mar; 34(3):270-7. PubMed ID: 12673562
[TBL] [Abstract][Full Text] [Related]
55. [Fanconi syndrome in an adult coincident with early myeloma with monoclonal IgG, type kappa, anomaly (author's transl)].
Walb D; Wohlenberg H; Rumpelt HJ; Schmidt H; Thomas L
Dtsch Med Wochenschr; 1980 Sep; 105(39):1355-9. PubMed ID: 6257469
[TBL] [Abstract][Full Text] [Related]
56. Diagnosis and monitoring a case of light-chain deposition disease in the kidney using a new, sensitive immunoassay.
Brockhurst I; Harris KP; Chapman CS
Nephrol Dial Transplant; 2005 Jun; 20(6):1251-3. PubMed ID: 15784642
[TBL] [Abstract][Full Text] [Related]
57. A molecular basis for nonsecretory myeloma.
Coriu D; Weaver K; Schell M; Eulitz M; Murphy CL; Weiss DT; Solomon A
Blood; 2004 Aug; 104(3):829-31. PubMed ID: 15090444
[TBL] [Abstract][Full Text] [Related]
58. Cytoplasmic immunoglobulins in bone marrow cells of polyclonal and of monoclonal origin.
Morell A; Skvaril F; Huser HJ; Spengler G; Barandun S
Acta Haematol; 1978; 60(3):137-47. PubMed ID: 101001
[TBL] [Abstract][Full Text] [Related]
59. [Renal disorders associated with monoclonal gammopathies: diagnostic and therapeutic progress].
Bridoux F; Delbes S; Sirac C; Pourreau F; Puyade M; Desport E; Jaccard A; Fermand JP; Touchard G
Presse Med; 2012 Mar; 41(3 Pt 1):276-89. PubMed ID: 22244725
[TBL] [Abstract][Full Text] [Related]
60. Individual serum proteins and acute phase reactants in monoclonal immunoglobulinopathies (a study in patients with IgA myeloma and light chain myeloma).
Wiedermann D; Widermann B; Cídl K; Scudla V
Neoplasma; 1979; 26(3):315-24. PubMed ID: 119165
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
